glp-1 agonist therapy information platforms Receptor Market Size & Analysis, 2026-2033 Upcoming wave of hormone-based therapies
Description
Lancet Diabetes Endocrinol 2021;9(10):653662
2018;26:931 Li Y, Tian H, Zeng H, Zhang Y, Yin T, He H, et al
Other GLP-1RAs (liraglutide) also elevated phosphorylation of ERK with increased transcriptional activity and the inhibitors of PD98059 and GLP-1R siRNA partially blocked the liraglutide-induced ERK signaling activation (Wu et al., 2017)
Ferrier, G
